RT Journal Article
SR Electronic
T1 Epigenome-wide association studies identify novel DNA methylation sites associated with PTSD: A meta-analysis of 23 military and civilian cohorts
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2024.07.15.24310422
DO 10.1101/2024.07.15.24310422
A1 Katrinli, Seyma
A1 Wani, Agaz H
A1 Maihofer, Adam X
A1 Ratanatharathorn, Andrew
A1 Daskalakis, Nikolaos P
A1 Montalvo-Ortiz, Janitza
A1 Núñez-Ríos, Diana L
A1 Zannas, Anthony S
A1 Zhao, Xiang
A1 Aiello, Allison E
A1 Ashley-Koch, Allison E
A1 Avetyan, Diana
A1 Baker, Dewleen G
A1 Beckham, Jean C
A1 Boks, Marco P
A1 Brick, Leslie A
A1 Bromet, Evelyn
A1 Champagne, Frances A
A1 Chen, Chia-Yen
A1 Dalvie, Shareefa
A1 Dennis, Michelle F
A1 Fatumo, Segun
A1 Fortier, Catherine
A1 Galea, Sandro
A1 Garrett, Melanie E
A1 Geuze, Elbert
A1 Grant, Gerald
A1 Hauser, Michael A
A1 Hayes, Jasmeet P
A1 Hemmings, Sian MJ
A1 Huber, Bertrand Russel
A1 Jajoo, Aarti
A1 Jansen, Stefan
A1 Kessler, Ronald C
A1 Kimbrel, Nathan A
A1 King, Anthony P
A1 Kleinman, Joel E
A1 Koen, Nastassja
A1 Koenen, Karestan C
A1 Kuan, Pei-Fen
A1 Liberzon, Israel
A1 Linnstaedt, Sarah D
A1 Lori, Adriana
A1 Luft, Benjamin J
A1 Luykx, Jurjen J
A1 Marx, Christine E
A1 McLean, Samuel A
A1 Mehta, Divya
A1 Milberg, William
A1 Miller, Mark W
A1 Mufford, Mary S
A1 Musanabaganwa, Clarisse
A1 Mutabaruka, Jean
A1 Mutesa, Leon
A1 Nemeroff, Charles B
A1 Nugent, Nicole R
A1 Orcutt, Holly K
A1 Qin, Xue-Jun
A1 Rauch, Sheila A M
A1 Ressler, Kerry J
A1 Risbrough, Victoria B
A1 Rutembesa, Eugène
A1 Rutten, Bart P F
A1 Seedat, Soraya
A1 Stein, Dan J
A1 Stein, Murray B
A1 Toikumo, Sylvanus
A1 Ursano, Robert J
A1 Uwineza, Annette
A1 Verfaellie, Mieke H
A1 Vermetten, Eric
A1 Vinkers, Christiaan H
A1 Ware, Erin B
A1 Wildman, Derek E
A1 Wolf, Erika J
A1 Young, Ross McD
A1 Zhao, Ying
A1 van den Heuvel, Leigh L
A1 ,
A1 ,
A1 ,
A1 Uddin, Monica
A1 Nievergelt, Caroline M
A1 Smith, Alicia K
A1 Logue, Mark W
YR 2024
UL http://medrxiv.org/content/early/2024/07/15/2024.07.15.24310422.abstract
AB Background The occurrence of post-traumatic stress disorder (PTSD) following a traumatic event is associated with biological differences that can represent the susceptibility to PTSD, the impact of trauma, or the sequelae of PTSD itself. These effects include differences in DNA methylation (DNAm), an important form of epigenetic gene regulation, at multiple CpG loci across the genome. Moreover, these effects can be shared or specific to both central and peripheral tissues. Here, we aim to identify blood DNAm differences associated with PTSD and characterize the underlying biological mechanisms by examining the extent to which they mirror associations across multiple brain regions.Methods As the Psychiatric Genomics Consortium (PGC) PTSD Epigenetics Workgroup, we conducted the largest cross-sectional meta-analysis of epigenome-wide association studies (EWASs) of PTSD to date, involving 5077 participants (2156 PTSD cases and 2921 trauma-exposed controls) from 23 civilian and military studies. PTSD diagnosis assessments were harmonized following the standardized guidelines established by the PGC-PTSD Workgroup. DNAm was assayed from blood using either Illumina HumanMethylation450 or MethylationEPIC (850K) BeadChips. A common QC pipeline was applied. Within each cohort, DNA methylation was regressed on PTSD, sex (if applicable), age, blood cell proportions, and ancestry. An inverse variance-weighted meta-analysis was performed. We conducted replication analyses in tissue from multiple brain regions, neuronal nuclei, and a cellular model of prolonged stress.Results We identified 11 CpG sites associated with PTSD in the overall meta-analysis (1.44e-09 < p < 5.30e-08), as well as 14 associated in analyses of specific strata (military vs civilian cohort, sex, and ancestry), including CpGs in AHRR and CDC42BPB. Many of these loci exhibit blood-brain correlation in methylation levels and cross-tissue associations with PTSD in multiple brain regions. Methylation at most CpGs correlated with their annotated gene expression levels.Conclusions This study identifies 11 PTSD-associated CpGs, also leverages data from postmortem brain samples, GWAS, and genome-wide expression data to interpret the biology underlying these associations and prioritize genes whose regulation differs in those with PTSD.Competing Interest StatementCYC is an employee of Biogen. NPD has served on scientific advisory boards for BioVie Pharma, Circular Genomics and Sentio Solutions for unrelated work. NRN serves as an unpaid member of the Ilumivu advisory board. SAMR receives support from the Wounded Warrior Project (WWP), Department of Veterans Affairs (VA), National Institute of Health (NIH), McCormick Foundation, Tonix Pharmaceuticals, Woodruff Foundation, and Department of Defense (DOD). Dr. Rauch receives royalties from Oxford University Press and American. KJR serves as a consultant for Acer, Bionomics, and Jazz Pharma; SABs for Sage, Boehringer Ingelheim, and Senseye. DJS has received consultancy honoraria from Discovery Vitality, Johnson and Johnson, Kanna, LOreal, Lundbeck, Orion, Sanofi, Servier, Takeda and Vistagen. MBS has in the past 3 years received consulting income from Acadia Pharmaceuticals, Aptinyx, atai Life Sciences, BigHealth, Biogen, Bionomics, BioXcel Therapeutics, Boehringer Ingelheim, Clexio, Delix Therapeutics, Eisai, EmpowerPharm, Engrail Therapeutics, Janssen, Jazz Pharmaceuticals, NeuroTrauma Sciences, PureTech Health, Sage Therapeutics, Sumitomo Pharma, and Roche/Genentech. MBS has stock options in Oxeia Biopharmaceuticals and EpiVario. MBS has been paid for his editorial work on Depression and Anxiety (Editor-in-Chief), Biological Psychiatry (Deputy Editor), and UpToDate (Co-Editor-in-Chief for Psychiatry). MBS has also received research support from NIH, Department of Veterans Affairs, and the Department of Defense. MBS is on the scientific advisory board for the Brain and Behavior Research Foundation and the Anxiety and Depression Association of America.Funding StatementThis work was supported by the National Institute of Mental Health (NIMH; R01MH108826 and R01MH106595). This work was also supported by I01BX003477, a Department of Veterans Affairs BLR&D grant to MWL; 1R03AG051877, 1R21AG061367-01, RF1AG068121, and 1I01CX001276-01A2 to EJW; R21MH102834, 5I01CX000431, 5R01MH079806 to MWM; R01MD011728 to MU; R01MH105379 to NRN; R01MH117291, R01MH117292, R01MH117293 to FAC; R01MH108826 to NPD; U01MH115485 to LM, SF, SJ, JM, AU, and DEW; R01MH117291, R01MH117292, R01MH117293 to JEK; CDC NIOSH U01OH012466 to PFK; R01MH117291, R01MH117292, R01MH117293 to CBN; R01MH093500 to CMN; 1R15MH099521-01, 5R21MH085436-02, 1R15HD049907-01A1 to HKO; R01MH108826 to AKS; I01BX002577, IK2CX000525, and lK6BX003777 to NAK; U01MH110925 to SAM; R21DA050160 and 1DP1DA058737 to JMO; Department of Veterans Affairs B9254‐C to WM, B3001-C to CF; Department of Defense W81XWH-11-1-0073 and the National Center for Advancing Translational Sciences of the NIH UL1TR000433PEC-PTSD to SAMR; BX006186; BX005872 to VBR; VIDI award (91718336) from the Netherlands Scientific Organization to BPFR; Dutch Research Council (NWO) VIDI grant (09150171910042) to CHV. Brainomics work was supported by R01MH117291, R01MH117292, and R01MH117293. DJS and NK was supported by the South African Medical Research Council and the Bill and Melinda Gates Foundation (OPP 1017641). SS is supported by the South African Medical Research Council. SK is supported by the BIRCWH of the National Institutes of Health under Award Number K12HD085850.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:IRBs of each respective institution (Lifespan Hospitals, University of Michigan, University of North Carolina at Chapel Hill, University of Cape Town,Stellenbosch University,the Western Cape Provincial Health Research, Emory University, Northern Illinois University, University Teaching Hospital of Kigali, College of Medicine and Health Sciences at the University of Rwanda, Stony Brook University, the Queensland University of Technology, Greenslopes Private Hospital, University of California San Diego, VA San Diego Research Service, Naval Health Research Center, University Medical Center Utrecht, Uniformed Services University of the Health Sciences for the Henry M. Jackson Foundation, the Institute for Social Research at the University of Michigan, VHAAAHS, VASDHCS, CHSVAMC, MGH, the Department of Defense Human Research Protection Office, Boston VA Healthcare System, Salisbury VA, Hampton VA, Durham VA and Duke University Medical Centers) gave ethical approval for this work.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesThe main summary statistics data that support the findings of this study will be available within Supplementary Data upon publication. Individual-level data from the cohorts or cohort-level summary statistics will be made available to researchers following an approved analysis proposal through the PGC-PTSD Epigenetics Workgroup with agreement of the cohort PIs. The raw data for the GTP cohort is available in the Gene Expression Omnibus database with the accession code GSE132203. Owing to military cohort data sharing restrictions, data from the VA, VA MIRECC, MRS, Army STARRS, PRISMO, PROGrESS, and NCPTSD/TRACTS cannot be publicly posted. However, such data can be provided in de-identified from a data repository through a data use agreement following applicable guidelines on data sharing and privacy protection. For additional information on access to these data, including PI contact information for the contributing cohorts, please contact the corresponding author.